NET PROFIT (x1000 SEK)
EMPLOYEES
Biocrine AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
4
|
36
|
12 |
Earnings before taxes |
-9,803
|
-7,449
|
-8,492 |
EBITDA |
-9,863
|
-7,421
|
-7,036 |
Total assets |
13,295
|
21,103
|
13,633 |
Current assets |
427
|
9,524
|
2,977 |
Current liabilities |
3,629
|
1,634
|
715 |
Equity capital |
9,666
|
19,469
|
12,918 |
- share capital |
285
|
271
![]() |
271 |
Employees (average) |
8
![]() |
8
![]() |
8 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.7%
|
92.3%
|
94.8% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-73.7%
|
-35.1%
|
-62.2% |
Current ratio |
11.8%
|
582.9%
|
416.4% |
Return on equity (ROE) |
-101.4%
|
-38.3%
|
-65.7% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
|
-1 |
Chg. No. of employees % |
0%
![]() |
0%
|
-11% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.